SMAD3 and neoplasm: Meanwhile, the delivery of such tumor-derived EVs to CD8+ T cells sets SMAD3 and TCF1 transcription factors in motion, consequently leading to the exhaustion of CD8+ T cells and minimizing their anti-tumor function [174, 175].